Delving into the Latest Updates on BioFocus DPI AG with Synapse

概览

关联

3

项与 BioFocus DPI AG 相关的药物

BF-66851

靶点

ROCK1

作用机制

ROCK1抑制剂

在研机构-

原研机构

BioFocus DPI AG

在研适应症-

非在研适应症

哮喘 [+6]

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

THR-5XXX

靶点-

作用机制-

在研机构-

原研机构

Theracos, Inc.

在研适应症-

非在研适应症

糖尿病

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

TNF alpha inhibitor (Arthrogen)

靶点

TNF-α

作用机制

TNF-α抑制剂

在研机构-

原研机构

MeiraGTx Netherlands BV

在研适应症-

非在研适应症

类风湿关节炎

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

100 项与 BioFocus DPI AG 相关的临床结果

登录后查看更多信息

0 项与 BioFocus DPI AG 相关的专利（医药）

登录后查看更多信息

1

项与 BioFocus DPI AG 相关的文献（医药）

Special Publication - Royal Society of Chemistry

A unique natural product platform applied to the discovery of novel compounds with activity against the malaria parasite, Plasmodium falciparum

作者: Beyer, Kim ; Avery, Vicky M. ; Witzig, Robert ; Bathurst, Ian ; Eckard, Peter ; Duffy, Sandra ; Kemmler, Michael

A review.The need for novel compounds combined with technol. advances in natural product chem. has nourished the recent renaissance of natural products in drug discovery.The Medicines for Malaria Venture (MMV), in collaboration with BioFocus DPI and the Eskitis Institute for Cell and Mol. Therapies (Eskitis), has established a drug Functional Mols. from Natural Sources discovery program that will enable the identification of small mols. derived from natural sources to become new therapies for fighting malaria.This collaboration is based on key strengths of BioFocus DPI and Eskitis, expertise in natural products drug discovery and anti-malarial HTS.Here we will present BioFocus DPI's approach.

100 项与 BioFocus DPI AG 相关的药物交易

登录后查看更多信息

100 项与 BioFocus DPI AG 相关的转化医学

登录后查看更多信息